Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enanta Pharmaceuticals (ENTA) Change in Acquisitions & Divestments (2016 - 2025)

Historic Change in Acquisitions & Divestments for Enanta Pharmaceuticals (ENTA) over the last 14 years, with Q3 2025 value amounting to $72.4 million.

  • Enanta Pharmaceuticals' Change in Acquisitions & Divestments rose 15827.0% to $72.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $262.9 million, marking a year-over-year decrease of 3144.82%. This contributed to the annual value of $262.9 million for FY2025, which is 3144.82% down from last year.
  • According to the latest figures from Q3 2025, Enanta Pharmaceuticals' Change in Acquisitions & Divestments is $72.4 million, which was up 15827.0% from $59.7 million recorded in Q2 2025.
  • Enanta Pharmaceuticals' Change in Acquisitions & Divestments' 5-year high stood at $134.5 million during Q4 2023, with a 5-year trough of $26.7 million in Q1 2022.
  • Its 5-year average for Change in Acquisitions & Divestments is $76.9 million, with a median of $72.4 million in 2023.
  • Its Change in Acquisitions & Divestments has fluctuated over the past 5 years, first surged by 21073.18% in 2023, then tumbled by 7651.46% in 2024.
  • Enanta Pharmaceuticals' Change in Acquisitions & Divestments (Quarter) stood at $108.8 million in 2021, then fell by 4.29% to $104.1 million in 2022, then rose by 29.22% to $134.5 million in 2023, then plummeted by 42.28% to $77.6 million in 2024, then fell by 6.79% to $72.4 million in 2025.
  • Its last three reported values are $72.4 million in Q3 2025, $59.7 million for Q2 2025, and $53.2 million during Q1 2025.